Beverley Greenwood-Van Meerveld Selected Research

Visceral Pain

11/2021	A Monoclonal Anti-Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity.
1/2021	Amygdala microglia modify neuronal plasticity via complement C1q/C3-CR3 signaling and contribute to visceral pain in a rat model.
1/2020	Sex differences in the epigenetic regulation of chronic visceral pain following unpredictable early life stress.
1/2020	Importance of Non-pharmacological Approaches for Treating Irritable Bowel Syndrome: Mechanisms and Clinical Relevance.
1/2020	Critical evaluation of animal models of visceral pain for therapeutics development: A focus on irritable bowel syndrome.
1/2019	Targeting epigenetic mechanisms for chronic visceral pain: A valid approach for the development of novel therapeutics.
1/2018	Visceral hypersensitivity induced by optogenetic activation of the amygdala in conscious rats.
1/2017	Stress-Induced Chronic Visceral Pain of Gastrointestinal Origin.
1/2016	The Pharmacology of Visceral Pain.
10/2014	Synergistic effect of 5-hydroxytryptamine 3 and neurokinin 1 receptor antagonism in rodent models of somatic and visceral pain.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Beverley Greenwood-Van Meerveld Research Topics

Disease

26	Hypersensitivity (Allergy) 01/2022 - 03/2003
16	Pain (Aches) 01/2021 - 02/2003
15	Visceral Pain 11/2021 - 03/2003
8	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2021 - 04/2011
8	Inflammation (Inflammations) 01/2020 - 01/2004
6	Hyperalgesia 01/2020 - 01/2012
6	Ileus 01/2019 - 09/2007
4	Abdominal Pain (Pain, Abdominal) 01/2021 - 04/2011
4	Nociceptive Pain 01/2020 - 02/2010
4	Diarrhea 01/2019 - 07/2003
4	Colitis 11/2011 - 01/2004
2	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2020 - 06/2018
2	Neoplasms (Cancer) 01/2020 - 10/2008
2	Constipation 01/2018 - 01/2008
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2017 - 10/2008
2	Chronic Pain 04/2016 - 11/2014
2	Gastroparesis 01/2012 - 10/2008
1	Migraine Disorders (Migraine) 11/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Neuralgia (Stump Neuralgia) 01/2020
1	Acute Pain 11/2014
1	Body Weight (Weight, Body) 06/2009

Drug/Important Bio-Agent (IBA)

10	CorticosteroneIBA 01/2018 - 07/2003
5	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022 - 01/2012
5	Ghrelin ReceptorsIBA 01/2020 - 09/2007
5	Hormones (Hormone)IBA 01/2018 - 04/2011
5	GlucocorticoidsIBA 01/2013 - 07/2003
4	Corticotropin-Releasing HormoneIBA 01/2021 - 02/2006
4	GhrelinIBA 01/2020 - 10/2008
3	Histones (Histone)IBA 11/2021 - 01/2017
3	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2008
3	ipamorelinIBA 01/2020 - 06/2009
3	Acetic Acid (Vinegar)FDA LinkGeneric 01/2020 - 03/2003
3	Cholinergic Agents (Cholinergics)IBA 01/2019 - 11/2007
3	Steroid Receptors (Steroid Receptor)IBA 06/2015 - 02/2010
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2012 - 02/2009
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2012 - 06/2007
3	Trinitrobenzenesulfonic AcidIBA 11/2011 - 10/2005
2	Minocycline (Cyclops)FDA LinkGeneric 01/2021 - 01/2020
2	linaclotideIBA 01/2021 - 01/2018
2	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2021 - 01/2018
2	HM01IBA 01/2020 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2017 - 01/2016
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017 - 11/2014
2	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 10/2014 - 03/2003
2	Messenger RNA (mRNA)IBA 06/2012 - 02/2006
2	ulimorelinIBA 02/2009 - 09/2007
2	Opioid Analgesics (Opioids)IBA 01/2008 - 11/2007
2	Morphine (MS Contin)FDA LinkGeneric 01/2008 - 11/2007
2	Peroxidase (Myeloperoxidase)IBA 11/2007 - 01/2004
1	Calcitonin Gene-Related PeptideIBA 11/2021
1	AntigensIBA 11/2021
1	theasinensin AIBA 11/2021
1	Histone Deacetylase InhibitorsIBA 11/2021
1	AntibodiesIBA 11/2021
1	Immunoglobulin FragmentsIBA 11/2021
1	trichostatin A (A 300)IBA 11/2021
1	Biopolymers (Biopolymer)IBA 01/2021
1	Investigational DrugsIBA 01/2021
1	OKN 007IBA 01/2021
1	Complement C1q (C1q Complement)IBA 01/2021
1	Claudin-2IBA 01/2020
1	Biological ProductsIBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Chemokine CX3CL1IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2019
1	CytokinesIBA 01/2019
1	Protamines (Protamine Sulfate)FDA Link 06/2018
1	ChannelrhodopsinsIBA 01/2018
1	Halorhodopsins (Halorhodopsin)IBA 01/2018
1	OpsinsIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 04/2016
1	netupitantIBA 10/2014
1	Palonosetron (Aloxi)FDA Link 10/2014
1	CRF receptor type 2IBA 10/2014
1	Serotonin 5-HT3 Receptor AntagonistsIBA 10/2014
1	Serotonin (5 Hydroxytryptamine)IBA 10/2014
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 10/2014
1	Estradiol (Delestrogen)FDA LinkGeneric 03/2013
1	Estrogens (Estrogen)FDA Link 03/2013
1	sym-trinitrobenzeneIBA 01/2013
1	Sulfonic AcidsIBA 01/2013
1	Ion Channels (Ion Channel)IBA 10/2012
1	Adrenocorticotropic Hormone (ACTH)FDA Link 06/2012
1	(3,6- dimethyl- 2- (2,4,6- trimethylphenoxy)pyridin- 4- yl)(1- ethylpropyl)amineIBA 06/2012
1	Serotonin ReceptorsIBA 04/2012
1	PeptidomimeticsIBA 01/2012
1	SteroidsIBA 04/2011
1	Growth Hormone (Somatotropin)IBA 06/2009
1	SecretagoguesIBA 06/2009

Therapy/Procedure

11	Therapeutics 01/2021 - 03/2003
3	Oral Administration 11/2011 - 03/2003
2	Enema (Enemas) 11/2007 - 10/2005
2	Spinal Cord Stimulation 10/2005 - 02/2003
1	Traction 01/2020
1	Lasers (Laser) 01/2018
1	Cannula 01/2018
1	Ovariectomy (Oophorectomy) 03/2013